Update on systemic treatment in early triple negative breast cancer

Update on systemic treatment in early triple negative breast cancer

Triple negative breast cancer (TNBC) is a heterogeneous disease representing about 15% of all breast cancers. TNBC are usually high-grade histological tumors, and are generally more aggressive and difficult to treat due to the lack of targeted therapies available, and chemotherapy remains the standa...

Full description

Bibliographic Details
Main Authors: Martín Núñez Abad, Silvia Calabuig-Fariñas, Miriam Lobo de Mena, María José Godes Sanz de Bremond, Clara García González, Susana Torres Martínez, José Ángel García-García, Vega Iranzo González-Cruz, Carlos Camps Herrero
Format: Article
Language:English
Published: SAGE Publishing 2021-01-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758835920986749

Internet

https://doi.org/10.1177/1758835920986749

Similar Items